Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment
Open Access
- 1 January 2007
- journal article
- Published by Springer Nature in Molecular Neurodegeneration
- Vol. 2 (1), 20
- https://doi.org/10.1186/1750-1326-2-20
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptorsProceedings of the National Academy of Sciences, 2007
- Transcriptional regulation of macrophage cholesterol trafficking by PPARα and LXRBiochemical Society Transactions, 2006
- Reciprocal and Coordinate Regulation of Serum Amyloid A Versus Apolipoprotein A-I and Paraoxonase-1 by Inflammation in Murine HepatocytesArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Cholesterol secretion and homeostasis in chondrocytes: a liver X receptor and retinoid X receptor heterodimer mediates apolipoprotein A1 expressionMatrix Biology, 2005
- 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitors Attenuate β-Amyloid-Induced Microglial Inflammatory ResponsesJournal of Neuroscience, 2005
- Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenalsJournal of Molecular Endocrinology, 2004
- Coadministration of a Liver X Receptor Agonist and a Peroxisome Proliferator Activator Receptor-α Agonist in Mice: Effects of Nuclear Receptor Interplay on High-Density Lipoprotein and Triglyceride Metabolism in VivoJournal of Pharmacology and Experimental Therapeutics, 2004
- Role of apoE/Aβ interactions in Alzheimer's disease: insights from transgenic mouse modelsMolecular Psychiatry, 2002
- The inflammation-induced pathological chaperones ACT and apo-E are necessary catalysts of Alzheimer amyloid formationNeurobiology of Aging, 2001
- Apolipoprotein A-I Directly Interacts with Amyloid Precursor Protein and Inhibits Aβ Aggregation and ToxicityBiochemistry, 2001